Skip to content
Rohit K. Katial

Rohit K. Katial, MD, is an allergist and immunologist at National Jewish Health. Dr. Katial is in the Division of Allergy and Clinical Immunology.



Special Interests


Research Interests

Asthma airway inflammation and biomarkers.

Education


Education

1987 - 1991
Georgetown University School of Medicine (Washington, DC), MD
1982 - 1986
Georgetown University (Washington DC), BS, Physics
1987
Catholic University of America (Washington, DC), BEE

Residency

1996 - 1997
Walter Reed Army Medical Center (Washington, DC), Clinical Laboratory Immunology
1994 - 1996
Fitzsimons AMC/National Jewish Health (Denver, CO), Allergy & Immunology
1992 - 1994
Eisenhower Army Medical Center (Fort Gordon, GA), Internal Medicine

Awards & Recognition


September 2019: Castle Connolly Top Doctors
August 2019: Selected to the Top Doctors by 5280: Denver’s Magazine
September 2018: Castle Connolly Top Doctors
August 2018: Selected to Best Doctors in America® Best Doctors, Inc.
September 2017: Castle Connolly Top Doctors
August 2017: Selected to the Top Doctors by 5280: Denver’s Magazine
August 2017: Selected to Best Doctors in America® Best Doctors, Inc.
September 2016: Castle Connolly Top Doctors
August 2016: Selected to the Top Doctors by 5280: Denver’s Magazine
August 2016: Selected to Best Doctors in America® 2015-2016 — Best Doctors, Inc.
September 2015: Castle Connolly Top Doctors
August 2015: Selected to the Top Doctors by 5280: Denver’s Magazine
August 2015: US News and World Report Top Doctor Award for Allergy and Immunology

Board Certification


1994, 2004, 2014: American Board of Internal Medicine
1997, 2007, 2019: American Board of Allergy & Immunology
1997: Specialty Certification in Clinical Laboratory Immunology
1989, 1991, 1992: National Board of Medical Examiners, Parts I, II, III

Professional Memberships


1994-Present: American Academy of Allergy, Asthma, and Immunology, Fellow (FAAAAI)
1994-Present: American College of Allergy, Asthma and Immunology, Fellow (FACAAI)
1991-Present: American College of Physicians, Fellow (FACP)
1997-Present: Clinical Immunology Society

Publications


Chung Y, Katial R, Mu F, Cook EE, Young J, Yang D, Betts KA, Carstens DD.Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.Ann Allergy Asthma Immunol. 2022 Jun;128(6):669-676.e6. doi: 10.1016/j.anai.2022.02.017. Epub 2022 Mar 2.

Menzies-Gow A, Kreindler J, Katial R, Gurnell M. Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy - Authors' reply. Lancet Respir Med. 2021 Nov 8:S2213-2600(21)00489-6. doi: 10.1016/S2213-2600(21)00489-6.

Humphries SM, Centeno JP, Notary AM, Gerow J, Cicchetti G, Katial RK, Beswick DM, Ramakrishnan VR, Alam R, Lynch DA. Volumetric assessment of paranasal sinus opacification on computed tomography can be automated using a convolutional neural network. Int Forum Allergy Rhinol. 2020 Apr 19.

Virchow JC, Katial R, Brusselle G, Shalit Y, Garin M, McDonald M, Castro M. Safety of reslizumab in uncontrolled asthma with eosinophilia: a pooled analysis from six trials.J Allergy Clin Immunol Pract. 2019 Aug 9. pii: S2213-2198(19)30701-9.

Fernández Pérez ER, Hunter M, Katial RK.  United States trends in mortality rates for primary immunodeficiency diseases.  J Allergy Clin Immunol Pract. 2019 Mar;7(3):1045-1048.

Academic Affiliations


Faculty Affiliate, University of Colorado School of Medicine

Teaching & Professional Positions


Associate Vice President of Education
Director, Center for Clinical Immunology
Irene J & Dr. Abraham E. Goldminz, Chair in Immunology and Respiratory Medicine

Conflicts of Interest


National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.